Previous close | 86.37 |
Open | 86.44 |
Bid | 85.92 x 800 |
Ask | 86.99 x 900 |
Day's range | 85.83 - 86.72 |
52-week range | 57.55 - 86.72 |
Volume | |
Avg. volume | 689,357 |
Market cap | 8.712B |
Beta (5Y monthly) | 0.82 |
PE ratio (TTM) | 22.65 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.60 (0.69%) |
Ex-dividend date | 01 Jul 2024 |
1y target est | N/A |
STERIS' (STE) fourth-quarter performance in AST is dented by a decline in capital equipment revenues. The contraction of margins is concerning.
Charles River's (CRL) Manufacturing and RMS business segments report organic revenue growth.
Robust revenues from the Screening and Precision Oncology segments contributed to the Exact Sciences' (EXAS) first-quarter top line.